Clémentine Sarkozy

7.5k total citations
73 papers, 1.4k citations indexed

About

Clémentine Sarkozy is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Clémentine Sarkozy has authored 73 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pathology and Forensic Medicine, 35 papers in Oncology and 21 papers in Genetics. Recurrent topics in Clémentine Sarkozy's work include Lymphoma Diagnosis and Treatment (58 papers), Chronic Lymphocytic Leukemia Research (20 papers) and CAR-T cell therapy research (15 papers). Clémentine Sarkozy is often cited by papers focused on Lymphoma Diagnosis and Treatment (58 papers), Chronic Lymphocytic Leukemia Research (20 papers) and CAR-T cell therapy research (15 papers). Clémentine Sarkozy collaborates with scholars based in France, United States and Canada. Clémentine Sarkozy's co-authors include Bertrand Coiffier, Laurie H. Sehn, Alexandra Traverse‐Glehen, Gilles Salles, Fabrice Jardin, Emmanuel Bachy, Vincent Ribrag, Hervé Tilly, Hervé Ghesquières and Franck Morschhauser and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Clémentine Sarkozy

65 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clémentine Sarkozy France 20 1.0k 791 371 263 219 73 1.4k
Sandrine Roulland France 16 1.1k 1.0× 715 0.9× 506 1.4× 370 1.4× 135 0.6× 43 1.5k
Carsten Hirt Germany 18 774 0.7× 449 0.6× 433 1.2× 181 0.7× 197 0.9× 42 1.1k
Jamie Hirata United States 17 1.1k 1.0× 1.0k 1.3× 425 1.1× 92 0.3× 159 0.7× 64 1.4k
Enrica Marchi United States 21 1.2k 1.2× 558 0.7× 248 0.7× 430 1.6× 246 1.1× 88 1.7k
Javier Muñoz United States 23 886 0.9× 1.2k 1.5× 545 1.5× 357 1.4× 84 0.4× 133 1.8k
Ferdinando Frigeri Italy 19 437 0.4× 339 0.4× 483 1.3× 211 0.8× 100 0.5× 60 1.2k
Gareth P. Gregory Australia 16 421 0.4× 495 0.6× 221 0.6× 290 1.1× 119 0.5× 74 956
Tim Svenstrup Poulsen Denmark 17 309 0.3× 323 0.4× 194 0.5× 324 1.2× 54 0.2× 71 896
Ana Pilar González Spain 17 286 0.3× 524 0.7× 258 0.7× 164 0.6× 87 0.4× 45 1.0k

Countries citing papers authored by Clémentine Sarkozy

Since Specialization
Citations

This map shows the geographic impact of Clémentine Sarkozy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clémentine Sarkozy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clémentine Sarkozy more than expected).

Fields of papers citing papers by Clémentine Sarkozy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clémentine Sarkozy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clémentine Sarkozy. The network helps show where Clémentine Sarkozy may publish in the future.

Co-authorship network of co-authors of Clémentine Sarkozy

This figure shows the co-authorship network connecting the top 25 collaborators of Clémentine Sarkozy. A scholar is included among the top collaborators of Clémentine Sarkozy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clémentine Sarkozy. Clémentine Sarkozy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aymard, M., Morgane Cheminant, Roch Houot, et al.. (2025). Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group. Blood Advances. 10(1). 75–82.
2.
Ribrag, Vincent, Dominique Bron, Grzegorz Rymkiewicz, et al.. (2025). Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet. The Lancet Haematology. 12(2). e138–e150. 1 indexed citations
3.
Shanmugam, Vignesh, et al.. (2024). Follicular lymphoma research: an open dialogue for a collaborative roadmap. Histopathology. 86(1). 79–93. 1 indexed citations
4.
Sarkozy, Clémentine, Benoît Tessoulin, & David Chiron. (2024). Unraveling MCL biology to understand resistance and identify vulnerabilities. Blood. 145(7). 696–707. 4 indexed citations
5.
Aymard, M., Morgane Cheminant, Roch Houot, et al.. (2024). Outcome of Patients with Mantle Cell Lymphoma after Failure of Anti-CD19 CAR T-Cell Therapy: A Descar-T Study By Lysa Group. Blood. 144(Supplement 1). 239–239.
6.
Linton, Kim, Lena Specht, Astrid Pavlovsky, et al.. (2023). Personalised therapy in follicular lymphoma – is the dial turning?. Hematological Oncology. 42(6). e3205–e3205. 4 indexed citations
7.
Cheson, Bruce D., Franck Morschhauser, Sarit Assouline, et al.. (2023). A PHASE 1 STUDY EVALUATING PRT2527, A POTENT AND HIGHLY SELECTIVE CDK9 INHIBITOR, IN PATIENTS WITH SELECT RELAPSED/REFRACTORY B‐CELL MALIGNANCIES. Hematological Oncology. 41(S2). 829–830. 1 indexed citations
8.
Saleh, Khalil, Morgane Cheminant, David Chiron, et al.. (2022). Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma. Cancers. 14(13). 3229–3229. 15 indexed citations
9.
Nissen, Michael, Xuehai Wang, Clémentine Sarkozy, et al.. (2021). Immune Profiling of Diagnostic DLBCL Biopsies Dramatically Improves upon Cell-of-Origin Risk Stratification. Blood. 138(Supplement 1). 719–719.
10.
Michot, Jean‐Marie, Maxime Annereau, Alina Danu, et al.. (2021). Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma. Cancer Drug Resistance. 4(3). 710–718. 3 indexed citations
11.
Sarkozy, Clémentine, Julien Lazarovici, Stéphane Champiat, et al.. (2021). Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation?. Human Vaccines & Immunotherapeutics. 17(10). 3502–3510. 1 indexed citations
12.
Sarkozy, Clémentine, Franck Morschhauser, Sydney Dubois, et al.. (2020). A LYSA Phase Ib Study of Tazemetostat (EPZ-6438) plus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) with Poor Prognosis Features. Clinical Cancer Research. 26(13). 3145–3153. 54 indexed citations
13.
Quivoron, Cyril, Jean‐Marie Michot, Valérie Camara‐Clayette, et al.. (2020). 66P High incidence of TP53 and epigenetic modifying oncogene mutations in a large cohort of patients enrolled in phase I clinical trials for R/R DLBCL. Annals of Oncology. 31. S1237–S1237. 1 indexed citations
14.
Tessoulin, Benoît, Kamal Bouabdallah, Barbara Burroni, et al.. (2020). Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA. Annals of Hematology. 99(8). 1771–1778. 9 indexed citations
15.
Quivoron, Cyril, Jean‐Marie Michot, Valérie Camara‐Clayette, et al.. (2020). High Incidence of TP53 and Epigenetic Modifying Oncogenes Mutations in a Large Cohort of Patients Enrolled in Phase 1 Clinical Trials for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Blood. 136(Supplement 1). 10–11. 1 indexed citations
16.
Bal, Antonin, Clémentine Sarkozy, Laurence Josset, et al.. (2018). Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management. Viruses. 10(11). 633–633. 26 indexed citations
17.
Sarkozy, Clémentine, Thierry Jo Molina, Hervé Ghesquières, et al.. (2016). Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association. Haematologica. 102(1). 150–159. 33 indexed citations
18.
19.
Sarkozy, Clémentine & Bertrand Coiffier. (2015). Primary refractory diffuse large B cell lymphoma in the rituximab era. Current Opinion in Oncology. 27(5). 377–383. 16 indexed citations
20.
Sarkozy, Clémentine, Nicolas Mounier, Alain Delmer, et al.. (2014). Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSA. 2014. 1–12. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandrine Roulland Breakdown of academic impact, for papers by Carsten Hirt Breakdown of academic impact, for papers by Jamie Hirata Breakdown of academic impact, for papers by Enrica Marchi Breakdown of academic impact, for papers by Javier Muñoz Breakdown of academic impact, for papers by Ferdinando Frigeri Breakdown of academic impact, for papers by Gareth P. Gregory Breakdown of academic impact, for papers by Tim Svenstrup Poulsen Breakdown of academic impact, for papers by Ana Pilar González
Rankless by CCL
2026